Search Results
Oct 09, 2025, 09:30 ET HUBLOT E DANIEL ARSHAM APRESENTAM O MP-17 ARSHAM SPLASH: UMA EVOLUÇÃO FLUIDA DA RELOJOARIA ARTÍSTICA
Exceptional Timepieces superam todas as expectativas com criações relojoeiras sem precedentes. Com sua disruptiva abordagem de desafiar as convenções, o DNA da Hublot é traduzido nos movimentos Unico, Meca-10 e Turbilhão que ela mesma desenvolveu internamente, adicionando mais uma camada de significado à
More news about: Hublot SA
Oct 09, 2025, 09:30 ET HUBLOT UND DANIEL ARSHAM PRÄSENTIEREN DIE MP-17 ARSHAM SPLASH: DIE JÜNGSTE EVOLUTION EINER FLUIDEN, KÜNSTLERISCHEN HAUTE HORLOGERIE
schaffen. Auch die in der eigenen Manufaktur entwickelten und produzierten Uhrwerke – Unico, Meca-10 und Tourbillonkaliber – tragen die rebellische DNA in sich, die Hublot dazu antreibt, die Konventionen ein ums andere Mal herauszufordern. Damit fügen sie der Kunst der Fusion eine weitere Bedeutungsebene
More news about: Hublot SA
Oct 09, 2025, 09:00 ET Syntax DnA³ Unites AI, Automation, and Analytics to Drive Smarter, Faster Enterprises
launch of Syntax DnA³, its Digital Innovation Center of Excellence that unites AI, automation, and analytics to help organizations unlock their data's full value and achieve faster, smarter business transformation. Built on Syntax's innovation portfolio, services, and industry expertise, DnA³ creates a trusted
More news about: Syntax
Oct 09, 2025, 08:00 ET Gap Inc. Sets Out to Reimagine Retail Powered by Google Cloud's AI
of every employee, we are freeing Gap Inc. teams to focus on creativity, culture, and customer connection while keeping the company's human-centered DNA at the core of innovation," Gerjets added. With AI strengthening its platform, Gap Inc. and Google Cloud are driving innovation,
More news about: Gap Inc.
Oct 09, 2025, 07:30 ET Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Threat-Level pathogen". He further stated: "While our lead DNA pol IIIC inhibitor is Phase 3-ready for oral treatment of C. difficile Infection, and has validated the bacterial target for DNA pol IIIC inhibitors, our new preclinical compounds are systemically absorbed for
More news about: Acurx Pharmaceuticals, Inc.
Oct 09, 2025, 07:00 ET Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
Company has developed a new generation of nanopore-based sensing technology that is currently used for information-rich, rapid, accessible and affordable DNA and RNA analysis. The platform is also being developed for the analysis of proteins and metabolites. The technology is being used in more than 125 countries
More news about: Bio-Techne Corporation
Oct 09, 2025, 06:00 ET Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
understand mechanisms of resistance to therapy in hematological cancers and to predict combination synergy and relevant biomarker candidates involving DNA Damage Repair mechanisms. About TurbineTurbine is virtualizing experiments with AI to accelerate
More news about: Turbine
Oct 08, 2025, 17:31 ET Hereditary Transthyretin Amyloidosis Market Forecasts Strong Growth Amid New Treatment Launches | DelveInsight
CRISPR-Cas9 gene editing is a revolutionary genome-editing technology that enables precise and targeted changes to DNA within living cells. Intellia Therapeutics' Nexiguran Ziclumeran is an investigational, in vivo CRISPR-Cas9 gene-editing therapy designed to treat
More news about: DelveInsight Business Research, LLP
Oct 08, 2025, 12:52 ET GenAspire, Software Formerly Known as "Copper Banking," Partners with Open Banking Solutions
Unions Open Banking Solutions is led by the team that built community-focused financial solutions like the DNA Platform. These are fintech veterans who have proven experience in building successful solutions that have created positive impact within
More news about: Open Banking Solutions
Oct 08, 2025, 12:27 ET Rotary Air Preheaters Market Size to Reach USD 1.8 Billion by 2033, Growing at 5.2% CAGR from 2026-2033 - Market Research Intellect
Programs, Diagnostic Confirmation in Symptomatic Patients), By Product (High-Performance Liquid Chromatography (HPLC) Testing, Molecular Genetic Testing (DNA-Based), Hemoglobin Electrophoresis, Next-Generation Sequencing (NGS), Point-of-Care (POC) Rapid Tests), By Region, and Forecast to 2033
More news about: Market Research Intellect
Oct 08, 2025, 11:34 ET Mindfulness Meditation Apps Market Set to Surge from USD 1.2 Billion in 2024 to USD 3.2 Billion by 2033, Experiencing a Robust CAGR of 14.5% - Market Research Intellect
And Share By Application (HPV Testing, Pap Smear Screening, Biopsy Analysis, Imaging and Molecular Diagnostics), By Product (Cytology-Based Tests, HPV DNA Tests, Molecular Diagnostic Assays, Colposcopy and Biopsy Techniques), Regional Outlook, And Forecast
More news about: Market Research Intellect
Oct 08, 2025, 11:00 ET Rosalind Franklin University Launches Doctor of Nursing Practice Program in Adult-Gerontology Acute Care
embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Oct 08, 2025, 09:19 ET Dual Class Actions Filed by Milberg and Krause & Kinsman Target Harcros Chemicals: Community Seeks Accountability and Medical Monitoring
problems. Conditions include elevated rates of cancer (including breast and blood cancers), severe reproductive health impacts, DNA mutations, diminished capacity to fight future disease, and increased mortality rates/reduced life expectancy among the exposed.
More news about: Milberg Coleman Bryson Phillips Grossman PLLC
Oct 08, 2025, 09:00 ET Cycode Enters the Gartner® Magic Quadrant™ for Application Security Testing (AST), 2025
With hundreds of vendors evaluated in this category, we believe our inclusion highlights the strength of our convergence strategy and our AI-Native DNA. This is integral to the future of secure AI development, as AI security and governance of AI agents are becoming paramount to the overall software supply
More news about: Cycode
Oct 08, 2025, 08:30 ET ImmunoVec Launches from Stealth with up to $40.7 Million ARPA-H EMBODY Award to Advance In Vivo Cell Engineering Platform for Autoimmune Diseases
Novel platform uses DNA-loaded polymeric nanoparticles to precisely reprogram cells in patients, offering potential to reset the immune system and transform treatment for life-threatening autoimmune diseases
More news about: ImmunoVec
Oct 08, 2025, 07:30 ET Hunting Parasites to Save Animal Lives - From the Deep Sea to the Family Dog: MiDOG Expands Veterinary Genomics with First Set of Parasite Reference Genomes in Collaboration with the University of Nebraska's Harold W. Manter Laboratory of Parasitology
companion animals and wildlife, publicly available through the National Center for Biotechnology Information (NCBI). This milestone extends MiDOG's DNA-based diagnostics beyond bacteria, viruses, and fungi, addressing a critical gap in animal health: parasites.
More news about: MiDOG Animal Diagnostics
Oct 08, 2025, 07:00 ET Greenvit Introduces its Pure Aronia extract at Supply Side West
antioxidant. In fact, it has one of the highest capacities of any berry for absorbing reactive oxygen species (ROS). Over time, ROS have been shown to damage DNA and disrupt cell structure and function, causing inflammation, which, as scientific research indicates, is inherent in metabolic diseases." explains
More news about: Greenvit
Oct 07, 2025, 18:20 ET Klotho Neurosciences Announces Expiration of Letter of Intent
ALS, Alzheimer's disease, and Parkinson's disease. The Company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. Klotho is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical
More news about: Klotho Neurosciences, Inc.
Oct 07, 2025, 17:31 ET AHR Agonists Market Trends Signal Promising Growth in Immunology and Dermatology Therapeutics | DelveInsight
until a ligand activates it. Once activated, it moves into the nucleus, forms a dimer with ARNT, and binds to Xenobiotic Response Elements (XREs) in DNA to trigger the expression of specific target genes. Additionally, AHR interacts with other transcription factors, influencing wider gene networks.
More news about: DelveInsight Business Research, LLP
Oct 07, 2025, 16:04 ET TruDiagnostic Awarded NIH SBIR Grant to Advance Breakthrough Epigenetic Diagnostic Technology
Institutes of Health (NIH). The funding supports development of the company's W-Function Epigenomic Roadmap, a next-generation model for understanding how DNA methylation changes over time to predict and prevent chronic disease.
More news about: TruDiagnostic
Oct 07, 2025, 14:11 ET Circulogene Expands Solid Tumor Genomic Capabilities with Launch of OncoGenDx Tissue Assay
across all solid tumor types. Built on Roche's AVENIO NGS platform and leveraging FoundationOne's bioinformatics pipeline, the assay interrogates 335 DNA genes and 72 RNA genes to identify single nucleotide variants (SNVs), insertions/deletions (Indels), copy number variations (CNVs), and structural variants
More news about: Circulogene
Oct 07, 2025, 10:00 ET BODYARMOR SPORTS DRINK DEBUTS BOLD NEW LOOK AND "CHOOSE BETTER™" CAMPAIGN IN CANADA
ingredients, better taste, and no artificial flavours, sweeteners, or dyes. While the category has evolved since BODYARMOR first hit the scene in 2011, its DNA remains unchanged: bold, authentic, and unapologetically real. Now, BODYARMOR is bringing that same edge to Canada. The brand
More news about: BA Sports Nutrition, LLC.
Oct 07, 2025, 09:30 ET Pablo Prichard, MD Reveals Science-based Model that Aims to Slow Age Progression
explained using an everyday object: a wheel. Referred to as the "Wheel of Age" Dr. Prichard is vocal on the belief that cellular senescence, genomic DNA damage, epigenetic damage, organ damage, protein damage, stem cell exhaustion, hormone dysfunction and microbiome damage are all spokes on the wheel.
More news about: Forever Young with Dr. Pablo Prichard
Oct 07, 2025, 09:21 ET Human-Machine Collaboration, User Co-Creation, and Ecological Sharing -- 2025 Chery International User Summit Is About to Begin
Group's proprietary AI model. This represents more than a display of technology — it symbolises how Chery Group's automotive DNA empowers the robotics industry. Drawing on decades of expertise in precision manufacturing, quality management, and system integration,
More news about: Chery International
Oct 07, 2025, 09:00 ET XSE Self Sculpt Introduces the High Power Diet™ -- A Systems-Engineered Nutrition Framework Leveraging DNA Insights
alignment without compromise. DNA Precision Meets Intelligent Nutrition A defining feature of the High Power Diet is its integration of DNA insights — enabling clients to align nutrition and fitness strategies with
More news about: XSE Self Sculpt